Skip to main content

Table 1 Demographic and Clinical Characteristics of 141,286 Women who Delivered throughout Florida in 2001

From: Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset

 

Elevated Antiphospholipid Antibody Titers

 

Present

(n = 88)

Absent

(n = 141,198)

Variable

Number (Percent)

Number (Percent)

Age (years) *

  

   11–19

2 (2.27)

16,155 (11.44)

   20–29

33 (37.50)

72,316 (51.22)

   30–39

47 (53.41)

48,751 (34.53)

   40–49

6 (6.82)

3,964 (2.81)

   ≥ 50

0 (0.0)

12 (0.01)

Race-ethnicity

  

   Black

12 (13.64)

32,940 (23.33)

   White Hispanic

15 (17.05)

29,520 (20.91)

   White Non-Hispanic

57 (64.77)

70,529 (49.95)

   Other

4 (4.55)

8,209 (5.81)

Medicaid

  

   Yes

16 (18.18)

58,333 (41.31)

   No

72 (81.82)

82,865 (58.69)

Hospital mortality

0 (0.0)

21 (0.01)

Preeclampsia or eclampsia

10 (11.36)

6,265 (4.44)

Systemic lupus erythematosus

5 (5.68)

126 (0.09)

Placental insufficiency

6 (6.82)

2,347 (1.66)

Prolonged length of stay (> 3 days)

34 (38.64)

18,808 (13.32)

  1. * Median age (range) of APS patients = 30.5 years (18 years-43 years) and median age of patients free of APS (range) = 27 years (11 years-54 years)